MassMutual Private Wealth & Trust FSB boosted its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 11.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 103,494 shares of the industrial products company's stock after purchasing an additional 10,913 shares during the quarter. MassMutual Private Wealth & Trust FSB's holdings in Xylem were worth $13,388,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Valley National Advisers Inc. boosted its position in Xylem by 84.9% during the 1st quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock valued at $26,000 after purchasing an additional 101 shares during the period. Perkins Coie Trust Co bought a new stake in Xylem during the 1st quarter valued at $27,000. Center for Financial Planning Inc. raised its stake in Xylem by 52.0% during the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after acquiring an additional 91 shares in the last quarter. Headlands Technologies LLC raised its stake in Xylem by 90.6% during the 1st quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company's stock valued at $36,000 after acquiring an additional 145 shares in the last quarter. Finally, Heck Capital Advisors LLC bought a new stake in Xylem during the 4th quarter valued at $36,000. Institutional investors and hedge funds own 87.96% of the company's stock.
Xylem Stock Performance
Shares of XYL stock opened at $141.98 on Tuesday. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $145.33. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The company has a market capitalization of $34.56 billion, a price-to-earnings ratio of 36.88, a P/E/G ratio of 2.45 and a beta of 1.09. The stock's fifty day simple moving average is $138.41 and its 200-day simple moving average is $127.67.
Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The business had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.20 billion. During the same quarter in the previous year, the company posted $1.09 earnings per share. Xylem's revenue for the quarter was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, sell-side analysts predict that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.
Xylem Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th will be paid a $0.40 dividend. The ex-dividend date is Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem's payout ratio is 41.56%.
Insider Buying and Selling
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business's stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the transaction, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. The trade was a 25.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.27% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Several analysts have weighed in on the company. TD Cowen lifted their target price on Xylem from $125.00 to $130.00 and gave the company a "hold" rating in a research note on Tuesday, August 26th. JPMorgan Chase & Co. assumed coverage on Xylem in a research note on Friday, May 30th. They set an "overweight" rating and a $148.00 target price on the stock. Wall Street Zen raised Xylem from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Citigroup reaffirmed a "buy" rating and set a $152.00 target price (up previously from $137.00) on shares of Xylem in a research note on Monday, July 14th. Finally, Cowen reissued a "hold" rating on shares of Xylem in a research note on Tuesday, August 26th. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $150.75.
Get Our Latest Report on XYL
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.